These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28446752)

  • 1. Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability.
    Wang X; Li SH; Zhu L; Nian QG; Yuan S; Gao Q; Hu Z; Ye Q; Li XF; Xie DY; Shaw N; Wang J; Walter TS; Huiskonen JT; Fry EE; Qin CF; Stuart DI; Rao Z
    Nat Commun; 2017 Apr; 8(1):14. PubMed ID: 28446752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone.
    Zhao Z; Date T; Li Y; Kato T; Miyamoto M; Yasui K; Wakita T
    J Gen Virol; 2005 Aug; 86(Pt 8):2209-2220. PubMed ID: 16033968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
    Yang J; Yang H; Li Z; Wang W; Lin H; Liu L; Ni Q; Liu X; Zeng X; Wu Y; Li Y
    Viruses; 2017 Jan; 9(1):. PubMed ID: 28117725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
    Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM
    PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.
    Lee E; Hall RA; Lobigs M
    J Virol; 2004 Aug; 78(15):8271-80. PubMed ID: 15254199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice.
    Mathenge EGM; Parquet MDC; Funakoshi Y; Houhara S; Wong PF; Ichinose A; Hasebe F; Inoue S; Morita K
    J Gen Virol; 2004 Sep; 85(Pt 9):2503-2513. PubMed ID: 15302944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acidity/Alkalinity of Japanese Encephalitis Virus E Protein Residue 138 Alters Neurovirulence in Mice.
    Zheng X; Zheng H; Tong W; Li G; Wang T; Li L; Gao F; Shan T; Yu H; Zhou Y; Qiu Y; Ma Z; Tong G
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30158291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localizations of NS3 and E proteins in mouse brain infected with mutant strain of Japanese encephalitis virus.
    Wang JJ; Liao CL; Yang CI; Lin YL; Chiou CT; Chen LK
    Arch Virol; 1998; 143(12):2353-69. PubMed ID: 9930192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese encephalitis virus invasion of cell: allies and alleys.
    Nain M; Abdin MZ; Kalia M; Vrati S
    Rev Med Virol; 2016 Mar; 26(2):129-41. PubMed ID: 26695690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus.
    Lee E; Lobigs M
    J Virol; 2002 May; 76(10):4901-11. PubMed ID: 11967307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutation of Japanese encephalitis virus envelope protein residue 389 attenuates viral neuroinvasiveness.
    Huang R; He Y; Zhang C; Luo Y; Chen C; Tan N; Ren Y; Xu K; Yuan L; Yang J
    Virol J; 2024 Jun; 21(1):128. PubMed ID: 38840203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells.
    Zhou Y; Wu R; Zhao Q; Chang YF; Wen X; Feng Y; Huang X; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S
    Arch Virol; 2018 May; 163(5):1351-1355. PubMed ID: 29411136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
    Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
    BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the Japanese encephalitis virus envelope protein.
    Luca VC; AbiMansour J; Nelson CA; Fremont DH
    J Virol; 2012 Feb; 86(4):2337-46. PubMed ID: 22156523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full genome sequence and virulence analyses of the recent equine isolate of Japanese encephalitis virus.
    Shimojima M; Nagao Y; Shimoda H; Tamaru S; Yamanaka T; Matsumura T; Kondo T; Maeda K
    J Vet Med Sci; 2011 Jun; 73(6):813-6. PubMed ID: 21233594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
    Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
    Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies.
    Qiu X; Lei Y; Yang P; Gao Q; Wang N; Cao L; Yuan S; Huang X; Deng Y; Ma W; Ding T; Zhang F; Wu X; Hu J; Liu SL; Qin C; Wang X; Xu Z; Rao Z
    Nat Microbiol; 2018 Mar; 3(3):287-294. PubMed ID: 29379207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus.
    Liu H; Liu Y; Wang S; Zhang Y; Zu X; Zhou Z; Zhang B; Xiao G
    J Virol; 2015 May; 89(10):5668-86. PubMed ID: 25762738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DC-SIGN Binding Contributed by an Extra N-Linked Glycosylation on Japanese Encephalitis Virus Envelope Protein Reduces the Ability of Viral Brain Invasion.
    Liang JJ; Chou MW; Lin YL
    Front Cell Infect Microbiol; 2018; 8():239. PubMed ID: 30042931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.